Clinical Trial: Construction of a Self-Management Program for Targeted Therapy-Related Cutaneous Adverse Reactions in Cancer Patients Based on the COM-B Model (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Construction of a Self-Management Program for Targeted Therapy-Related Cutaneous Adverse Reactions in Cancer Patients Based on the COM-B Model'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129497

Registration Time: 2026/08/05

Type: Interventional study

Primary Sponsor: Dongguan Songshan Lake Central Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=332614

Published by HT Digital Content Services with permission from Health Daily Digest....